ASP Isotopes Inc. is a pre-commercial stage advanced materials company. The Company has a license to use technology, the Aerodynamic Separation Process (ASP technology), originally developed and licensed to it by Klydon Proprietary Ltd (Klydon), for the production, distribution, marketing and sale of all isotopes. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Molybdenum-100 (Mo-100) and Silicon-28 (Si-28). It also intends to develop the ASP technology to produce enriched Uranium-235 (U-235). It operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for highly specialized end markets; Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market, and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the license agreement with Klydon.